Article

Accommodating lens available in 0.25-D steps

Aliso Viejo, CA-The FDA has given Eyeonics Inc. approval to market its Crystalens accommodating IOL in quarter-diopter steps. The approval makes eyeonics the first U.S. company to launch 0.25-D IOLs, the company said. The lenses were made available Nov. 1 to credentialed Crystalens surgeons.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) CCOI Myopia Workshop: Michael X. Repka, MD, MBA, on building consensus and future directions
(Image credit: Ophthalmology Times) Introducing iOpeners: Unpacking high-yield ophthalmology tips and clinical pearls, with Nicole Bajic, MD
© 2025 MJH Life Sciences

All rights reserved.